Simplex Trading
PLRX icon

Simplex Trading’s Pliant Therapeutics PLRX Stock Holding History

Simplex Trading’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.5K Buy
48,054
+2,142
+5% +$2.7K ﹤0.01% 5658
2025
Q4 		$56K Buy
45,912
+32,923
+253% +$49.5K ﹤0.01% 5557
2025
Q3 		$19K Sell
12,989
-297
-2% -$453 ﹤0.01% 7378
2025
Q2 		$15K Buy
13,286
+7,983
+151% +$11.3K ﹤0.01% 7020
2025
Q1 		$7K Buy
5,303
+725
+16% +$4.4K ﹤0.01% 7357
2024
Q4 		$60K Buy
4,578
+1,720
+60% +$23.5K ﹤0.01% 5687
2024
Q3 		$32K Buy
2,858
+1,165
+69% +$14.6K ﹤0.01% 6302
2024
Q2 		$18K Sell
1,693
-829
-33% -$10.7K ﹤0.01% 6992
2024
Q1 		$37K Sell
2,522
-1,675
-40% -$27.6K ﹤0.01% 6560
2023
Q4 		$76K Sell
4,197
-21,409
-84% -$326K ﹤0.01% 5651
2023
Q3 		$444K Buy
+25,606
New +$444K ﹤0.01% 3530
2023
Q2 		– Sell
-1,776
Closed -$42K – 9717
2023
Q1 		$47K Buy
+1,776
New +$50.6K ﹤0.01% 5990
2022
Q4 		– Sell
-3,461
Closed -$72.4K – 10136
2022
Q3 		$72K Sell
3,461
-8,823
-72% -$169K ﹤0.01% 5957
2022
Q2 		$98K Buy
12,284
+12,220
+19,094% +$78.2K ﹤0.01% 5579
2022
Q1 		$0 Buy
+64
New +$653 ﹤0.01% 11168

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Simplex Trading's PLRX Position: Q1 2026 in Review

Simplex Trading increased its Pliant Therapeutics (PLRX) stake by 4.7% in Q1 2026, buying an estimated $2.7K and bringing the position to 48,054 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5658.

Simplex Trading first reported a position in PLRX in Q1 2022 and has held it in 15 quarters since. The position peaked at $444K in Q3 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Simplex Trading held 48,054 shares of Pliant Therapeutics worth $60.5K as of Q1 2026.
  • Simplex Trading bought 2,142 Pliant Therapeutics shares in Q1 2026, an estimated $2.7K.
  • Pliant Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5658 holding.
  • Simplex Trading first reported a position in Pliant Therapeutics in Q1 2022 and has held it in 15 quarters since.
  • Simplex Trading's Pliant Therapeutics position peaked at $444K in Q3 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.